Internal Medicine, Nephrology · Glendale, AZ
NPI
1699778225
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5750 W Thunderbird Rd Ste F680
Glendale, AZ, 85306
Phone (602) 843-7171
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
2,037 services
Medicare patients, 2024
414
Average age 75
Drug cost, 2024
$157K
1,075 prescriptions
Company payments, 2025
$786
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ariv Swaminathan was code 99233 (hospital e&m - subsequent), 492 times for 197 patients. In total Ariv Swaminathan billed 2,037 services in 25 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 492 | 197 | $89.19 | $44K |
| 99215 Office E&M - Established | Office | 303 | 149 | $132.48 | $40K |
| 99223 Hospital E&M - Initial | Facility | 101 | 97 | $125.99 | $13K |
| 99291 Critical Care E&M | Facility | 65 | 28 | $153.87 | $10K |
| 99205 Office E&M - New | Office | 33 | 33 | $147.34 | $4,862 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 24 | $12.48 | $325 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 16 | $59.85 | $1,197 |
By year: 2022 $138K for 1,869 services; 2023 $170K for 2,198 services; 2024 $142K for 2,037 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ariv Swaminathan prescribed most often to Medicare patients was Perindopril Erbumine, with 100 prescriptions and refills. In total Ariv Swaminathan wrote 1,075 Medicare prescriptions that cost $157K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Perindopril Erbumine Generic | 100 | 288 | 33 | $9,515 |
| Calcitriol Generic | 79 | 202 | 28 | $1,980 |
| Amlodipine Besylate Generic | 65 | 191 | 26 | $416 |
| Allopurinol Generic | 39 | 106 | 13 | $421 |
| Furosemide Generic | 39 | 105 | 21 | $244 |
| Lisinopril Generic | 38 | 113 | 11 | $255 |
| Losartan Potassium Generic | 38 | 116 | 11 | $480 |
| Hydralazine Hcl Generic | 37 | 106 | 16 | $893 |
| Sevelamer Carbonate Generic | 37 | 60 | 12 | $7,617 |
| Potassium Chloride Generic | 35 | 101 | 15 | $476 |
| Clonidine Hcl Generic | 29 | 85 | Under 11 | $628 |
| Metoprolol Tartrate Generic | 29 | 84 | Under 11 | $355 |
| Carvedilol Generic | 27 | 61 | Under 11 | $196 |
| Gabapentin Generic | 25 | 39 | Under 11 | $285 |
| Nifedipine Er Nifedipine | 21 | 57 | Under 11 | $454 |
Brand drugs: 106 claims; generic drugs: 969 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ariv Swaminathan $786 ($786 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $195.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 3 | $195 |
| NxStage Medical, Inc. | 1 | $125 |
| Ardelyx, Inc. ARDX | 6 | $108 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $79.96 |
| Lilly USA, LLC LLY | 2 | $41.32 |
| Mallinckrodt Hospital Products Inc. | 2 | $41.06 |
| Akebia Therapeutics Inc AKBA | 1 | $27.84 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22.69 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $21.4 |
| CorMedix Inc. CRMD | 1 | $20.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.